Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1327-2019

Drug recall · June 19, 2019

Ipamorelin Acetate 9 mg/9mL Injectable vials recall

Why: Lack of Sterility Assurance.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Ipamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846

Lots / codes

Lot #: 05022019:50 Exp. 10/29/2019; 05082019:91 Exp. 06/08/2019

Quantity
11 vials
Company
Pharm D Solutions, LLC, Houston, TX
Distribution
Nationwide within the United States
Initiated
May 23, 2019 · FDA Mandated
Classified
June 7, 2019
Reported
June 19, 2019
Ended
February 5, 2021
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.